8-K ·Filed May 29, 2026

ANAB

ANAPTYSBIO, INC
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago SEC0001193125-26-248326
8-K context-dependent: Items 7.01
Actionable Insight • Neutral

No trading signal. The filing is purely informational regarding tax treatment of a prior spin-off. Monitor for any subsequent operational updates from AnaptysBio or First Tracks.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
ANAB ▲ +9.84% at T+60d
NEUTRAL call ✓ call won +9.84% · α vs SPY +8.61% · entry $53.14 → $58.37
Entry anchored
May 29, 03:59 PM ET
via exchange tick
T+1d
-3.54%
call -3.54% · α -3.69%
$51.26
settled 4mo ago
T+5d
-5.21%
call -5.21% · α -2.46%
$50.37
settled 4mo ago
T+20d
+27.02%
call +27.02% · α +28.32%
$67.50
settled 3mo ago
T+60d
+9.84%
call +9.84% · α +8.61%
$58.37
settled 5w ago

Price Chart

Loading chart...

Executive Summary

AnaptysBio filed an 8-K under Item 7.01 to disclose that it has filed Form 8937 with the IRS regarding the tax treatment of the spin-off of First Tracks Biotherapeutics, Inc. The filing provides stockholders with information on how the dividend is treated for tax purposes and how to adjust their tax basis. This is a routine administrative disclosure with no new financial or operational information.

Key Facts

  • AnaptysBio filed Form 8937 with the IRS related to the separation and spin-off of First Tracks Biotherapeutics, Inc.
  • The Form 8937 provides guidance on tax treatment of the dividend and change in tax basis for stockholders.
  • The information is furnished under Regulation FD and is not deemed filed for Exchange Act purposes.

Financial Impact

No financial figures disclosed; tax-basis guidance only.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (18 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-248326
Document: 0001193125-26-248326-index-headers.html0001193125-26-248326
Document: 0001193125-26-248326-index.html0001193125-26-248326
Document: 0001193125-26-248326.txt0001193125-26-248326
24 reports for ANAB
Performance horizon
67% Hit rate 12 of 18 directional calls best @ T+60▲ +41.26%Mar 3, 2026
Filters
Rows
Reports for ANAB — sortable, filterable
TypeNow
Aug 12, 2026
7w ago
Institutional Cluster
BULLISH ★ 5/10
$56.02 $53.87▼ −3.84%▼ −2.09%$48.53 (−13.37%)
Jun 29, 2026
13w ago
144
BEARISH ★ 6/10
$67.50 $53.61▲ +20.58%▲ +19.55%$48.53 (+28.10%)
Jun 29, 2026
13w ago
DEFA14A
NEUTRAL ★ 2/10
$67.50 $53.61▼ −20.58%▼ −19.55%$48.53 (−28.10%)
Jun 26, 2026
14w ago
144
BEARISH ★ 6/10
$65.97 $54.15▲ +17.92%▲ +17.64%$48.53 (+26.44%)
Jun 22, 2026
14w ago
8-K
NEUTRAL ★ 2/10
$59.43 $50.29▼ −15.38%▼ −16.54%$48.53 (−18.34%)
Jun 17, 2026
15w ago
144
BEARISH ★ 5/10
$57.51 $54.15▲ +5.84%▲ +6.38%$48.53 (+15.61%)
Jun 15, 2026
15w ago
144
BEARISH ★ 6/10
$57.61 $62.51▼ −8.51%▼ −8.31%$48.53 (+15.76%)
Jun 11, 2026
16w ago
144
BEARISH ★ 6/10
$56.07 $66.39▼ −18.41%▼ −16.63%$48.53 (+13.45%)
Jun 10, 2026
16w ago
144
BEARISH ★ 5/10
$54.24 $66.59▼ −22.77%▼ −20.88%$48.53 (+10.53%)
Jun 8, 2026
16w ago
144
BEARISH ★ 5/10
$51.63 $67.33▼ −30.40%▼ −28.95%$48.53 (+6.00%)
Showing 10 of 24

US Market Status

Market Closed — Opens Mon (38h 32m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access